Multi-omics in immunotherapy research for HNSCC: present situation and future perspectives

Area of Science:

• Oncology
• Immunology
• Bioinformatics

Background:

• Head and neck squamous cell carcinoma (HNSCC) is a prevalent cancer with significant impact.
• Immunotherapy offers improved survival but benefits only a subset of patients (15-20%), with unavoidable side effects.
• Understanding the HNSCC immune microenvironment is crucial for optimizing immunotherapy.

Purpose of the Study:

• To review the application of omics technologies in HNSCC immunotherapy research.
• To highlight how omics data can predict and enhance treatment efficacy.
• To explore the potential for personalized treatment strategies and novel immunotherapy targets.

Main Methods:

• Review of omics techniques (genomics, transcriptomics, proteomics, etc.).
• Analysis of bioinformatics approaches for interpreting complex biological data.
• Synthesis of current research on immune microenvironment characterization in HNSCC.

Main Results:

• Omics technologies provide insights into the HNSCC immune landscape.
• Applications include predicting immunotherapy response, enhancing efficacy, and developing personalized medicine.
• Omics facilitate the creation of advanced preclinical models and discovery of new therapeutic targets.

Conclusions:

• Omics-driven research is transforming HNSCC immunotherapy.
• Future directions involve advanced data integration, emerging technologies, and interdisciplinary collaboration.
• Personalized treatment strategies and novel target identification hold promise for improving patient outcomes.